Mainz Biomed Commits to Early Detection and Prevention of Colorectal Cancer
Mainz Biomed N.V., a molecular genetics diagnostic company, is proud to support Colorectal Cancer Awareness Month in March. The company recognizes the importance of early detection and proactive screening in improving survival rates for colorectal cancer (CRC) patients. Globally, CRC is the second leading cause of cancer-related deaths, with over 930,000 fatalities annually. In the … Read more